Item 7.01. Regulation FD.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press release datedJanuary 25, 2021 , entitled "Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL™ Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB)." 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source